P712-0413 Screening compound: 2-[8-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-1-(morpholin-4-yl)ethan-1-one

P712-0413 Screening compound: 2-[8-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-1-(morpholin-4-yl)ethan-1-one
P712-0413 Screening compound: 2-[8-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-1-(morpholin-4-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P712-0413
2-[8-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-1-(morpholin-4-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P712-0413

Molecular Formula

C17H18N6O3 (C17 H18 N6 O3)

Compound Name

2-[8-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-1-(morpholin-4-yl)ethan-1-one

IUPAC name

2-[8-(3-cyclopropyl-124-oxadiazol-5-yl)-[124]triazolo[43-a]pyridin-3-yl]-1-(morpholin-4-yl)ethan-1-one

SMILES

O=C(Cc1nnc2n1cccc2-c1nc(C2CC2)no1)N1CCOCC1

InChI

InChI=1S/C17H18N6O3/c24-14(22-6-8-25-9-7-22)10-13-19-20-16-12(2-1-5-23(13)16)17-18-15(21-26-17)11-3-4-11/h1-2,5,11H,3-4,6-10H2

InChI Key

FOXZQHKNTXYPKI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27613631

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

354.37

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.316

Distribution Coefficient, logD

0.316

Water Solubility, LogSw

-1.85

Polar Surface Area

79.330

Acid Dissociation Constant (pKa)

18.97

Base Dissociation Constant (pKb)

3.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.10

P712-0413 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

PI3K-Targeted Library (17255 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P712-0413 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P712-0413?
Check Price and Availability of P712-0413, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P712-0413 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P712-0413
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P712-0413
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P712-0413 available by request